<DOC>
	<DOC>NCT02377245</DOC>
	<brief_summary>The investigators created a cohort of patients with juvenile inflammatory rheumatisms with the purpose to follow them prospectively, and investigate the tolerance and efficacy of immunosuppresive and biological agents.</brief_summary>
	<brief_title>Juvenile Inflammatory Rheumatism (JIR) Cohorte</brief_title>
	<detailed_description>The JIR-cohort has to be filled by an authorized investigator during or after the consultation. Each patient much be followed at least once a year. Different data are requested in the JIR-cohort: diagnosis, treatment, adverse events and outcome.</detailed_description>
	<mesh_term>Arthritis, Juvenile</mesh_term>
	<criteria>Patients with juvenile inflammatory diseases Age at onset up to 18 years old Consent according national codes of ethics and current laws Nonconsent from patients and/or legal representative</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Juvenile</keyword>
	<keyword>Inflammatory</keyword>
	<keyword>Rheumatism</keyword>
	<keyword>Pediatric-Onset inflammatory diseases</keyword>
</DOC>